Non-steroidal anti-inflammatory drug (NSAID) use and levels of a lipid oxidation marker in plasma and nipple aspirate fluids

Breast Cancer Research and Treatment

Volumn 97, Issue 2, 2006, Pages 145-148

  Kato, Ikuko ^a   Chen, Gang ^b   Djuric, Zora ^c  

^a KARMANOS CANCER INSTITUTE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

15 F2t isoprostane; 8 isoprostane; Nipple aspirate fluids; Non steroidal anti inflammatory drugs; Oxidative stress

Indexed keywords

8 ISOPROSTANE; BIOCHEMICAL MARKER; CYCLOOXYGENASE 2 INHIBITOR; ISOPROSTANE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; CANCER RISK; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; LIPID PEROXIDATION; MEDIATOR RELEASE; NIPPLE; NORMAL HUMAN; OXIDATIVE STRESS; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; BODY FLUIDS; BREAST NEOPLASMS; FEMALE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; NIPPLES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS;

EID: 33646553594     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9102-y     Document Type: Article

References (25)

1. Khuder SA, Mutgi AB: Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84: 1188-1192, 2001
2. Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE: Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 14: 261-264, 2005
3. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI: Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291: 2433-2440, 2004
4. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE: Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47-55, 2005
5. Garcia Rodriguez LA, Gonzalez-Perez A: Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 91: 525-529, 2004
6. Swede H, Mirand AL, Menezes RJ, Moysich KB: Association of regular aspirin use and breast cancer risk. Oncology 68: 40-47, 2005
7. Johnson TW, Anderson KE, Lazovich D, Folsom AR: Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev 11: 1586-1591, 2002
8. Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L: Use of nonsteroidal anti-inflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. Am J Epidemiol 162: 165-170, 2005
9. Bundred NJ, Barnes NL: Potential use of COX-2-aromatase inhibitor combinations in breast cancer. Br J Cancer 93(Suppl 1): S10-15, 2005
10. Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, Fitzgerald GA, Lawson JA, Marnett LJ, et al.: Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 38: 711-718, 2005
11. Morrow JD, Roberts LJ, 2nd: Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 300: 3-12, 1999
12. Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB: Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 272: 209-215, 1999
13. Klein T, Reutter F, Schweer H, Seyberth HW, Nusing RM: Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. J Pharmacol Exp Ther 282: 1658-1665, 1997
14. Patrignani P: Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thromb Res 110: 281-286, 2003
15. Schweer H, Watzer B, Seyberth HW, Nusing RM: Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple- stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. J Mass Spectrom 32: 1362-1370, 1997
16. Chen G, Djuric Z: Detection of 2,6-cyclolycopene-1,5-diol in breast nipple aspirate fluids and plasma: a potential marker of oxidative stress. Cancer Epidemiol Biomarkers Prev 11: 1592-1596, 2002
17. Chen G, Heilbrun L, Venkatranamoorthy R, Djuric Z: Different factors affect changes in 8-isoprostane levels in plasma and breast nipple aspirate fluids during dietary intervention. Proc Am Assoc Cancer Res 43: 1340, 2004
18. Petrakis NL: Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev 2: 3-10, 1993
19. Gruenke LD, Wrensch MR, Petrakis NL, Miike R, Ernster VL, Craig JC: Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics. Cancer Res 47: 5483-5487, 1987
20. Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, et al.: Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 135: 130-141, 1992
21. Djuric Z, Poore KM, Depper JB, Uhley VE, Lababidi S, Covington C, Klurfeld DM, Simon MS, Kucuk O, Heilbrun LK: Methods to increase fruit and vegetable intake with and without a decrease in fat intake: compliance and effects on body weight in the Nutrition and Breast Health Study. Nutr Cancer 43: 141-151, 2002
22. Djuric Z, Visscher DW, Heilbrun LK, Chen G, Atkins M, Covington CY: Influence of lactation history on breast nipple aspirate fluid yields and fluid composition. Breast J 11: 92-99, 2005
23. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Jr., Montoye HJ, Sallis JF, Paffenbarger RS, Jr.: Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sport Exer 25: 71-80, 1993
24. Chen G, Heilbrun LK, Venkatramanamoorthy R, Maranci V, Redd JN, Klurfeld DM, Djuric Z: Effects of low-fat and/or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the Nutrition and Breast Health study. Nutr Cancer 50: 155-160, 2004
25. Freund R, Little R: Statistical Analysis System (SAS) for Linear Models. SAS Institute, Inc, Cary, NC, 1981